1. A novel defined risk signature of interferon response genes predicts the prognosis and correlates with immune infiltration in glioblastoma
   Yong Xiao et al, 2022, Mathematical Biosciences and Engineering CrossRef
2. Combination Therapy of Temozolomide, Ribavirin and Interferon-Beta for Glioblastoma In Vivo
   Genki Yazawa et al, 2023, Journal of Nihon University Medical Association CrossRef
3. Coriolus Versicolor and its Bioactive Molecule are Potential Immunomodulators Against Cancer Cell Metastasis Via Suppressing MMPs Expression Through Inactivation of MAPK Pathway
   Cindy LH Yang et al, SSRN Electronic Journal CrossRef
4. Glioblastoma as a Novel Drug Repositioning Target: Updated State
   Hamed Hosseinalizadeh et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef
5. Ratiometric Delivery of Mitoxantrone and Berberine Co-encapsulated Liposomes to Improve Antitumor Efficiency and Decrease Cardiac Toxicity
   Zimeng Yang et al, 2021, AAPS PharmSciTech CrossRef
6. Study of the Ribavirin drug adsorption on the surfaces of carbon nanotube and graphene nanosheet using density functional theory calculations
   Masoome Sheikhi et al, 2021, Bulletin of the Korean Chemical Society CrossRef
7. Promising Chemotherapy for Malignant Pediatric Brain Tumor in Recent Biological Insights
   Qian Zhou et al, 2022, Molecules CrossRef
8. Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery—A Comprehensive Review of the Literature
   Safwan Alomari et al, 2021, Biomolecules CrossRef
9. A comparative DFT study on Al- and Si- doped single-wall carbon nanotubes (SWCNTs) for Ribavirin drug sensing and detection
   Serap Senturk Dalgic et al, 2023, Materials Science in Semiconductor Processing CrossRef
10. Coriolus versicolor and its bioactive molecule are potential immunomodulators against cancer cell metastasis via inactivation of MAPK pathway
    Cindy Lai-Hung Yang et al, 2023, Journal of Ethnopharmacology CrossRef
11. Novel Synergistic Combination of Pamidronate and Temozolomide for Breast Cancer Therapeutics
    Zehra Hashim et al, 2023, Current Cancer Drug Targets CrossRef
12. The dark side of mRNA translation and the translation machinery in glioblastoma
    Angélica Montiel-Dávalos et al, 2023, Frontiers in Cell and Developmental Biology CrossRef